Clinical Trials Browser

Phase 1/2 × Brain Neoplasms × trebananib × Clear all

NCT01290263 2017-07-02

Amgen 386 for Recurrent Glioblastoma

Phase 1/2 Completed

48 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Glioma